Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.
Mingsight Pharmaceuticals has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Mingsight Pharmaceuticals's investors include Kaitai Capital.
Mingsight Pharmaceuticals is headquartered in San Diego, United States.
Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.
Mingsight Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mingsight Pharmaceuticals — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/mingsight-pharmaceuticals. Accessed October 4, 2026.
VCBacked. (2021). Mingsight Pharmaceuticals — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/mingsight-pharmaceuticals
{{cite web |title=Mingsight Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/mingsight-pharmaceuticals |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated